Showing results (1-10 of 6) with videos related to
Sort By:
Pageof 1
Anti-Cancer Drugs|July 20, 2005
Identification of a novel, orally bioavailable estrogen receptor downregulatorTakaaki Yoneya, Kenji Taniguchi, Toshiaki Tsunenari, et al.Anticancer Research|April 16, 2010
Thiochroman derivative CH4986399, a new nonsteroidal estrogen receptor down-regulator, is effective in breast cancer modelsTakaaki Yoneya, Kenji Taniguchi, Ryo Nakamura, et al.Oncology Reports|February 13, 2009
Effects of CH4893237, a new orally active estrogen receptor downregulator, on breast cancer xenograft models with low serum estrogen levelsTakaaki Yoneya, Toshiaki Tsunenari, Kenji Taniguchi, et al.Bioorganic & Medicinal Chemistry|April 4, 2006
Discovery of thiochroman and chroman derivatives as pure antiestrogens and their structure-activity relationshipYoshitake Kanbe, Myung-Hwa Kim, Masahiro Nishimoto, et al.Bioorganic & Medicinal Chemistry Letters|May 20, 2006
Discovery of thiochroman derivatives bearing a carboxy-containing side chain as orally active pure antiestrogensYoshitake Kanbe, Myung-Hwa Kim, Masahiro Nishimoto, et al.Bioorganic & Medicinal Chemistry Letters|June 30, 2006
Newly discovered orally active pure antiestrogensYoshitake Kanbe, Myung-Hwa Kim, Masahiro Nishimoto, et al.Pageof 1